Zhao S, et al. - This study was designed to assess long-term outcomes of hypofractionated radiotherapy (HF) and conventional fractioned radiotherapy (CF) in patients who underwent breast-conserving surgery for early-stage breast cancer. Furthermore, researchers also investigated cosmetic and delayed toxic effects in the breast. It was observed that long-term efficacy, cosmetic effects, and delayed toxic effects of hypofractionated and CF were comparable and therefore, HF may be used as an alternative to conventional fractionated radiotherapy.